Larvol Delta Tirzepatide: a new low for bodyweight and blood glucose The Lancet Diabetes & Endocrinology Zepbound Outperforms CagriSema in Head to Head Phase III Obesity Trial Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Retatrutide + Cagrilintide: The Weight Loss Stack Outperforming Ozempic [2026 Protocol]